Stephen M. Condon
Stephen M. Condon publishes mostly in Molecular Biology, Organic Chemistry and Immunology, on topics such as Cell death mechanisms and regulation, Synthetic Organic Chemistry Methods and Ubiquitin and proteasome pathways.
- World rank
- #1,689,967 of 7,710,434 ranked researchers
- Rank in United States
- #522,881 of 1,627,098
- Works
- 83
- Citations
- 3.8k
- Citations per work
- 46.0
What does Stephen M. Condon research?
Stephen M. Condon's work is mostly in Biochemistry, Genetics and Molecular Biology (37%), Chemistry (26%), Medicine (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences3643.9%
- Physical Sciences2125.9%
- Chemistry2125.9%
- Everything else1720.5%
- Health Sciences89.7%
- Medicine89.7%
- 1Molecular Biology32% of their works
- 2Organic Chemistry26% of their works
- 3Immunology7% of their works
- 4Oncology6% of their works
- 5Cancer Research4% of their works
- 6Epidemiology3% of their works
Research topics
Which keywords describe Stephen M. Condon's research?
The keywords of their largest research topics: Cancer Therapy, Apoptosis, Cell Death, Olefin Metathesis, Ruthenium Catalysts, Innate Immunity, Proteasome and Ubiquitin.
- Peptide Synthesis
- DNA
- Amination
- Enantioselective Reactions
- Ubiquitin
- Innate Immunity
- Olefin Metathesis
- Apoptosis
- Cancer Therapy
- Cell Death
- Ruthenium Catalysts
- Proteasome
- Viral Infection
- Organocatalysis
- Catalytic
- Drug Discovery
- Topoisomerases
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Cancer Therapy262 topics
- Apoptosis161 topic
- Cell Death161 topic
- Olefin Metathesis121 topic
- Ruthenium Catalysts121 topic
- Innate Immunity101 topic
- Proteasome101 topic
- Ubiquitin101 topic
- Viral Infection101 topic
- Enantioselective Reactions91 topic
- Organocatalysis91 topic
- Amination71 topic
- Catalytic71 topic
- DNA71 topic
- Drug Discovery71 topic
- Peptide Synthesis71 topic
- Topoisomerases71 topic
Where does Stephen M. Condon work?
Stephen M. Condon's main affiliation in the publication record is TetraLogic Pharmaceuticals (United States), United States.
How many publications and citations does Stephen M. Condon have?
OpenAlex counts 83 works and 3,817 citations for Stephen M. Condon, an h-index of 24, ranking #1,689,967 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Stephen M. Condon. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.